NCT00156780View on ClinicalTrials.gov

Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2004

Study Completion Date

July 31, 2005

Conditions
Congestive Heart FailureChronic Obstructive Pulmonary Disease
Interventions
DRUG

AI-700

Trial Locations (1)

02472

Acusphere, Inc., Watertown

Sponsors

Lead Sponsor

Acusphere
All Listed Sponsors
lead

Acusphere

INDUSTRY

NCT00156780 - Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF | Biotech Hunter | Biotech Hunter